β¨ Health Notices
4112 NEW ZEALAND GAZETTE No. 168
St Paulβs School, Massey.
The said supplementary integration agreement was executed
on 29 November 2001.
A copy of the supplementary integration agreement is
available for inspection without charge by any member of
the public at the regional office of the Ministry of
Education, 39-45 College Hill, Ponsonby, Auckland.
Dated at Wellington this 29th day of November 2001.
KATHY PHILLIPS, Senior Manager, National Operations.
go8563
Health
Burial and Cremation Act 1964
Appointment of Gore District Council to Have the Control and Management of Pukerau Cemetery
Pursuant to section 23 (3) of the Burial and Cremation Act 1964, the Governor-General has appointed the Gore District Council to have the control and management of the Pukerau Cemetery.
Dated at Wellington this 28th day of November 2001.
RUTH DYSON, Associate Minister of Health.
go8654
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Proleukin
Active Ingredient(s):
Aldesleukin 18MIU
Dosage Form:
Powder for injection
New Zealand Sponsor:
CSL (New Zealand) Limited
Manufacturer(s):
Chiron BV, Amsterdam, The Netherlands
Chiron Corporation, 4560 Horton Street, Emeryville, California, United States of America
Note: This consent is valid for 2 years from 27 January 2002.
Product:
Proleukin
Active Ingredient(s):
Aldesleukin 9MIU
Dosage Form:
Powder for injection
New Zealand Sponsor:
CSL (New Zealand) Limited
Manufacturer(s):
Chiron BV, Amsterdam, The Netherlands
Chiron Corporation, 4560 Horton Street, Emeryville, California, United States of America
Note: This consent is valid for 2 years from 27 January 2002.
Dated this 28th day of November 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go8556
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Loratadine
Active Ingredient(s):
Loratadine 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada
Product:
Videx EC
Active Ingredient(s):
Didanosine 125mg
Dosage Form:
Capsule
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 168
Gazette.govt.nz —
NZ Gazette 2001, No 168
β¨ LLM interpretation of page content
π Supplementary Integration Agreement for St Paul's School, Massey
π Education, Culture & Science29 November 2001
Private Schools Conditional Integration, St Paul's School, Massey
- KATHY PHILLIPS, Senior Manager, National Operations
π₯ Appointment of Gore District Council to Manage Pukerau Cemetery
π₯ Health & Social Welfare28 November 2001
Burial, Cremation, Cemetery Management, Gore District Council
- RUTH DYSON, Associate Minister of Health
π₯ Renewal of Provisional Consent for Proleukin
π₯ Health & Social Welfare28 November 2001
Medicines, Proleukin, Aldesleukin, CSL (New Zealand) Limited
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Consent to Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Apo-Loratadine, Loratadine, Videx EC, Didanosine